Treatment – Lifestyle Modifications
Written by: Ina Fried and Heather Morse | Last reviewed: December 2020
- Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm. Front Med (Lausanne). 2020 Mar 4;7:68. doi:10.3389/fmed.2020.00068.
- Jemec GBE. Clinical practice: hidradenitis suppurativa. N Engl J Med. 2012 Jan 12;366(2):158e64. doi:10.1056/NEJMcp1014163.
- Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76‐90.
- Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015 Jan;29(4):619-644. doi:10.1111/jdv.12966.
- Nazary M, van der Zee H, Prens E, et al., Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur J Pharmacol. 2011 Dec 15;672(1-3):1-8. doi:10.1016/j.ejphar.2011.08.047.
- Vazquez BG , Alikhan A, Weaver AL, et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota, J Invest Dermatol. 2013;133(1):97-103. doi:10.1038/jid.2012.255.
- Smith MK, Nicholson CL, Parks-Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Research. 2017 Jul 28;6(F1000 Faculty Rev):1272. doi:10.12688/11000research.11337.1.
- Collier E, Shi VY, Parvataneni RK, et al. Special considerations for women with hidradenitis suppurativa. Int J Womens Dermatol. 2020 Feb 19;6:85-88. doi:10.1016/j.ijwd.2020.02.005.
- Garg A, Kirby JS, Lavian J, et al. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017 Aug;153:760-764. doi:10.1001/jamadermatol.2017.0201.
- Calculate your body mass index. National Heart, Lung, and Blood Institute. Available at https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmicalc.htm. Accessed 8/28/2020.
- Tzellos T, Zouboulis CC. Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther (Heidelb). 2020;10(1):63‐71.
- Shah N. Hidradenitis suppurativa: a treatment challenge. Am Fam Physician. 2005 Oct 15;72(8):1547-1552.
- Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90(3):264-268.
- Machado MO, Stergiopoulos V, Maes M, et al. Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol. 2019 Jun 5. doi:10.1001/jamadermatol.2019.0759.